Emerging therapies for liver fibrosis (Q36478124)

14 August 2017

1 reference

title

Emerging therapies for liver fibrosis (English)

1 reference

14 August 2017

Andrew J Fowell

1

1 reference

PubMed ID

16699275

14 August 2017

John P Iredale

series ordinal

2

1 reference

14 August 2017

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

24

1 reference

14 August 2017

1-2

1 reference

14 August 2017

174-183

1 reference

Interactions between hepatic stellate cells and the immune system

14 August 2017

1 reference

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

21 January 2018

1 reference

Matrix as a modulator of hepatic fibrogenesis

21 January 2018

1 reference

Hepatic blood flow regulation by stellate cells in normal and injured liver

21 January 2018

1 reference

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking

21 January 2018

1 reference

Extracellular matrix degradation and the role of hepatic stellate cells

21 January 2018

1 reference

Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats

21 January 2018

1 reference

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

Hepatic stellate cell behavior during resolution of liver injury

21 January 2018

1 reference

The prognosis of patients with alcoholic liver disease. An international randomized, placebo-controlled trial on the effect of malotilate on survival.

21 January 2018

1 reference

Treatment of alcoholic hepatitis

21 January 2018

1 reference

Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.

21 January 2018

1 reference

Thalidomide ameliorates carbon tetrachloride induced cirrhosis in the rat.

21 January 2018

1 reference

Transfer of the interleukin-1 receptor antagonist gene into rat liver abrogates hepatic ischemia-reperfusion injury

21 January 2018

1 reference

Adenovirus-mediated gene transfer of interferon alpha inhibits hepatitis C virus replication in hepatocytes

21 January 2018

1 reference

A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C.

21 January 2018

1 reference

Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

21 January 2018

1 reference

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

21 January 2018

1 reference

A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture

21 January 2018

1 reference

Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression

21 January 2018

1 reference

Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat.

21 January 2018

1 reference

The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats.

21 January 2018

1 reference

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta

21 January 2018

1 reference

In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis

21 January 2018

1 reference

Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

21 January 2018

1 reference

Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats

21 January 2018

1 reference

Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats

21 January 2018

1 reference

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

21 January 2018

1 reference

Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis

21 January 2018

1 reference

Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat.

21 January 2018

1 reference

Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats

21 January 2018

1 reference

Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo

21 January 2018

1 reference

Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy

21 January 2018

1 reference

Fibrogenic and collagenolytic activity in carbon-tetrachloride-injured rats: beneficial effects of zinc administration.

21 January 2018

1 reference

Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells

21 January 2018

1 reference

Adenoviral-mediated transfer of p53 or retinoblastoma protein blocks cell proliferation and induces apoptosis in culture-activated hepatic stellate cells

21 January 2018

1 reference

Basal Expression of IκBα Is Controlled by the Mammalian Transcriptional Repressor RBP-J (CBF1) and Its Activator Notch1

21 January 2018

1 reference

Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis.

21 January 2018

1 reference

Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000090320

1 reference

14 August 2017

1 reference

PubMed ID

16699275